Virometix is offering co-development partnerships for vaccines against pneumococcal diseases, cervical cancer, respiratory viruses and other selected infectious diseases and chronic human diseases.

Virometix is also offering SVLP technology partnering and R&D collaborations in other application areas, including monoclonal antibody development, formulation of biologics and peptides and drug delivery.

For partnering enquiries, please contact us at Alternatively, you can meet us at the following upcoming conferences:




Grants & Awards

Our awards include the following